Document is current
Any future updates will be listed below
-
Authors
Sharma, Abhinav
Lövgren, Sandy Kang
Eriksson, Kajsa Ledesma
Wang, Yinxi
Robertson, Stephanie
Hartman, Johan
Rantalainen, Mattias
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 18 January 2024
Accepted: 6 August 2024
First Online: 14 August 2024
Declarations
:
: The study has approval from the Swedish Ethical Review Authority (2017/2106-31, with amendments 2018/1462-32 and 2019–02336). The study was performed in accordance with the Declaration of Helsinki. No additional informed consent was required in accordance with ethical approval in this non-interventional collection and analysis of data from patient records.
: Not Applicable.
: JH has obtained speaker’s honoraria or advisory board remunerations from Roche, Novartis, AstraZeneca, Pfizer, Eli Lilly, MSD and Gilead, and has received institutional research support from Cepheid, Novartis, Roche and AstraZeneca. MR and JH are co-founders and shareholders of Stratipath AB. SKL, KLE, YW and SR are employed by Stratipath AB and hold employee stock options. AS declares no conflicts of interest.
